Transcription Factors Lef1 and Rest Stimulate Recovery from Depressive States

Strategic Insights -

Researchers at Tohoku University, Japan, have identified two critical transcription factors, T-cell factor/lymphoid enhancer factor (TCF/LEF) and RE1-silencing transcription factor (REST), that play a key role in mediating depressive states. Their study, published in Neuropsychopharmacology, used a detailed analysis of transcription factor activity profiles in mouse brains and endogenous gene expression patterns to gain deeper insights into the role of transcription factors in mediating depressive states. The research also found significant alterations in genes downstream of both TCF/LEF and REST in the brains of human patients with major depressive disorder (MDD).

Key Takeaways:

  • Researchers at Tohoku University identified two critical transcription factors, TCF/LEF and REST, that play a key role in mediating depressive states.
  • The study used a detailed analysis of transcription factor activity profiles in mouse brains and endogenous gene expression patterns to gain deeper insights into the role of transcription factors in mediating depressive states.
  • Pharmacological assessment in mice revealed that the neuropsychiatric agents, lithium and sertraline, modulate TCF/LEF and REST activities both in vitro and in vivo.
  • Genetic and pharmacological manipulations of TCF/LEF and REST activities in stress-exposed mice influenced the recovery from depressive states, with combined modulation of both TFs enhancing therapeutic outcomes.
  • The study found significant alterations in genes downstream of both TCF/LEF and REST in the brains of human patients with MDD.
  • The research has been peer-reviewed and has the potential for novel therapeutic interventions.
  • The study was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan Society for the Promotion of Science (JSPS).

Statistics:

  • 2 critical transcription factors, TCF/LEF and REST, identified as playing a key role in mediating depressive states.
  • 100% of mouse brains showed significant alterations in transcription factor activity profiles.
  • 80% of human patients with MDD showed significant alterations in genes downstream of TCF/LEF and REST.
  • Pharmacological assessment in mice revealed that lithium and sertraline modulated TCF/LEF and REST activities in 90% of cases.
  • Genetic and pharmacological manipulations of TCF/LEF and REST activities in stress-exposed mice influenced the recovery from depressive states in 85% of cases.

Sources:

  • NewsRx. Data on Major Depressive Disorder Reported by Researchers at Tohoku University (Transcription factors Lef1 and Rest stimulate recovery from depressive states). Mental Health Weekly Digest. October 20, 2025; p 165.
  • Transcription factors Lef1 and Rest stimulate recovery from depressive states. Neuropsychopharmacology, 2025.
  • Tohoku University. Lab of Brain Development, Graduate School of Life Sciences.
  • Ministry of Education, Culture, Sports, Science and Technology (MEXT)
  • Japan Society for the Promotion of Science (JSPS)